Qube Research & Technologies (QRT)
SNDX icon

Qube Research & Technologies (QRT)’s Syndax Pharmaceuticals SNDX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$842K Sell
36,047
-652,090
-95% -$14.2M ﹤0.01% 2563
2025
Q4 		$14.5M Sell
688,137
-956,707
-58% -$16.7M 0.01% 1099
2025
Q3 		$25.3M Sell
1,644,844
-21,072
-1% -$276K 0.03% 783
2025
Q2 		$15.6M Buy
1,665,916
+831,067
+100% +$9.15M 0.02% 1022
2025
Q1 		$10.3M Buy
834,849
+110,433
+15% +$1.56M 0.01% 1127
2024
Q4 		$9.58M Buy
724,416
+41,214
+6% +$705K 0.01% 1115
2024
Q3 		$13.2M Buy
683,202
+385,899
+130% +$7.97M 0.02% 875
2024
Q2 		$6.1M Buy
297,303
+203,414
+217% +$4.26M 0.01% 1172
2024
Q1 		$2.23M Buy
93,889
+36,528
+64% +$815K ﹤0.01% 1692
2023
Q4 		$1.24M Sell
57,361
-149,033
-72% -$2.29M ﹤0.01% 1802
2023
Q3 		$3M Buy
206,394
+75,636
+58% +$1.43M 0.01% 1176
2023
Q2 		$2.74M Buy
130,758
+90,147
+222% +$1.88M 0.01% 919
2023
Q1 		$858K Buy
+40,611
New +$1.01M ﹤0.01% 1352
2022
Q2 		– Sell
-42,073
Closed -$731K – 3084
2022
Q1 		$731K Buy
+42,073
New +$708K 0.01% 1336
2020
Q3 		– Sell
-20,852
Closed -$309K – 2074
2020
Q2 		$309K Buy
+20,852
New +$318K ﹤0.01% 1286

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SNDX Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its Syndax Pharmaceuticals (SNDX) stake by 95% in Q1 2026, selling an estimated $14.2M and leaving 36,047 shares worth $842K. The position accounts for ﹤0.01% of the portfolio, ranked #2563.

Qube Research & Technologies (QRT) first reported a position in SNDX in Q2 2020 and has held it in 15 quarters since. The position peaked at $25.3M in Q3 2025. 246 funds tracked by Wall St. Rank hold SNDX as of Q1 2026.

  • Qube Research & Technologies (QRT) held 36,047 shares of Syndax Pharmaceuticals worth $842K as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 652,090 Syndax Pharmaceuticals shares in Q1 2026, an estimated $14.2M.
  • Syndax Pharmaceuticals made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #2563 holding.
  • Qube Research & Technologies (QRT) first reported a position in Syndax Pharmaceuticals in Q2 2020 and has held it in 15 quarters since.
  • Qube Research & Technologies (QRT)'s Syndax Pharmaceuticals position peaked at $25.3M in Q3 2025.
  • 246 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.